Scholars Central

Conference abstractPublished 3 Nov 2015

BRCA1-BRCT cancer-related point mutations alter sub-cellular localization of BRCA1 in vitro

Authors: Ioannis Drikos, Constantinos E Vorgias, Effrossyni Boutou

National and Kapodistrian University of Athens, Greece

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Mutations of the breast cancer susceptibility genes brca1 and brca2 account for 30âÂ?Â?50% of hereditary breast and ovarian cancer cases reported worldwide. The brca1 gene is the most extensively studied and a large number of mis-sense mutations are located in BRCT tandem repeats of the BRCA1 protein while only few of them are detrimental for the function as well as the interaction of BRCA1 with partner molecules. Mutations at the two C-terminal tandem (BRCT) repeats of BRCA1 detected in breast tumor patients have identified either to lower the stability of the BRCT domain and/or disrupt the interaction of BRCT with synthetic phosphopeptides. Such mutations, especially in the BRCT domain, may also result in the BRCA1 mis-localization due to modifications of BRCA1 binding to interacting proteins. Based on these data we sought to determine whether the M1775K and the V1809F destabilizing mutants of the BRCT domain do alter BRCA1 function in vitro, as shown by cell compartmentalization. The effects of these mutations on sub-cellular localization of BRCA1 protein were studied by following the expression of BRCA1wt and mutants fused to EGFP, in MCF-7 cells. The cytoplasmic mis-localization of M1775K and V1809F mutations which disrupt BRCA1 C-terminal folding, in contrast to the EGFP-BRCA1wt and the less affected variant M1652I, indicate that the functional changes might be crucial for BRCA1 nuclear transport. Additionally, the results compared with computational docking analysis in order to extract more informationâÂ?Â?s about the impact of the mutation to protein interactions. These data suggest that the impact of the integrity of the BRCA1-BRCT domain in structural level is crucial for proper function of the protein as shown by the modifications in its sub-cellular localization and may contribute to the deficiency of DNA repair procedure and cell cycle control observed in breast cancer cells.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Cancer Science & Therapy.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalCancer Science & Therapy
  • SubjectOncology & Cancer
  • BylineArticles whose byline prints “Ioannis Drikos”
  • BylineArticles whose byline prints “Constantinos E Vorgias”
  • BylineArticles whose byline prints “Effrossyni Boutou”